DXA Screening Found to Be Underused and Overused

Share this content:
DXA Screening Found to Be Underused and Overused
DXA Screening Found to Be Underused and Overused

(HealthDay News) -- Too few women at high risk for osteoporosis are being tested for the condition, while too many women at low risk are being screened, according to new research published online May 19 in the Journal of General Internal Medicine.

A team led by Anna Lee Amarnath, M.D., M.P.H., of the University of California, Davis, examined the medical records of 50,995 women, aged 40 to 85, living in the Sacramento area. The researchers looked at whether or not women were receiving dual-energy X-ray absorptiometry tests.

The result: Osteoporosis screening rates jumped sharply at age 50, despite guidelines suggesting that screening only begin at age 65, unless a woman has certain risk factors (body mass index <20 kg/m², glucocorticoid use, secondary osteoporosis, prior high-risk fracture, rheumatoid arthritis, alcohol abuse, and current smoking). The researchers also found that those risk factors had only a slight effect on a woman's decision to get tested. Over seven years, more than 42 percent of eligible women aged 65 to 74 were not screened, Amarath's team found, nor were nearly 57 percent of those older than 75. However, nearly 46 percent of low-risk women aged 50 to 59 were screened, as were 59 percent of low-risk women aged 60 to 64.

"Health systems should invest in developing electronic health records systems that prompt providers at the point-of-care when screening is needed and when it can be postponed," study senior author Joshua Fenton, M.D., M.P.H., an associate professor of family and community medicine at UC Davis, said in a journal news release.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

Dupilumab Reduces Rate of Severe Asthma Exacerbations

Dupilumab Reduces Rate of Severe Asthma Exacerbations

And, add-on dupilumab reduces glucocorticoid dose in patients with glucocorticoid-treated asthma

Better Social Support Network Protects Black Men Against HIV

Better Social Support Network Protects Black Men Against ...

Social networks of black men who have sex with men influence HIV risk behavior

Recommendations Developed for Managing Postpartum Pain

Recommendations Developed for Managing Postpartum Pain

Impact of medications on mother-infant dyad should be considered, as many women breastfeed

is free, fast, and customized just for you!

Already a member?

Sign In Now »